Advisor Group Holdings, Inc. Neurocrine Biosciences Inc Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 6,048 shares of NBIX stock, worth $825,733. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,048

Previous 5,875 2.94%

Holding current value

$825,733

Previous $808,000 13.86%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$114.58 - $153.15 $19,822 - $26,494	173 Added 2.94%	6,048 $696,000
Q2 2024 Aug 13, 2024	SELL	$130.86 - $143.19 $1.04 Million - $1.14 Million	-7,975 Reduced 57.58%	5,875 $808,000
Q1 2024 May 10, 2024	BUY	$130.4 - $143.74 $547,419 - $603,420	4,198 Added 43.49%	13,850 $1.91 Million
Q4 2023 Feb 12, 2024	BUY	$106.07 - $132.76 $14,955 - $18,719	141 Added 1.48%	9,652 $1.27 Million
Q3 2023 Nov 13, 2023	BUY	$94.02 - $117.1 $194,621 - $242,397	2,070 Added 27.82%	9,511 $1.07 Million
Q2 2023 Aug 10, 2023	SELL	$89.53 - $104.87 $485,163 - $568,290	-5,419 Reduced 42.14%	7,441 $701,000
Q1 2023 May 12, 2023	SELL	$94.11 - $123.02 $71,805 - $93,864	-763 Reduced 5.6%	12,860 $1.3 Million
Q4 2022 Feb 10, 2023	SELL	$106.72 - $127.06 $24,652 - $29,350	-231 Reduced 1.67%	13,623 $1.63 Million
Q3 2022 Nov 14, 2022	BUY	$92.03 - $107.81 $324,773 - $380,461	3,529 Added 34.18%	13,854 $1.47 Million
Q2 2022 Aug 10, 2022	BUY	$75.79 - $100.07 $21,145 - $27,919	279 Added 2.78%	10,325 $1.01 Million
Q1 2022 May 04, 2022	SELL	$72.45 - $94.81 $18,402 - $24,081	-254 Reduced 2.47%	10,046 $1.06 Million
Q3 2021 Nov 05, 2021	BUY	$86.18 - $99.03 $82,129 - $94,375	953 Added 10.2%	10,300 $990,000
Q2 2021 Aug 02, 2021	BUY	$89.43 - $102.27 $42,658 - $48,782	477 Added 5.38%	9,347 $910,000
Q1 2021 May 13, 2021	BUY	$87.57 - $119.4 $86,431 - $117,847	987 Added 12.52%	8,870 $863,000
Q4 2020 Feb 10, 2021	SELL	$86.91 - $108.33 $37,023 - $46,148	-426 Reduced 5.13%	7,883 $755,000
Q3 2020 Nov 12, 2020	BUY	$96.16 - $135.15 $370,216 - $520,327	3,850 Added 86.34%	8,309 $807,000
Q2 2020 Aug 14, 2020	SELL	$85.09 - $130.36 $204,556 - $313,385	-2,404 Reduced 35.03%	4,459 $531,000
Q1 2020 May 18, 2020	BUY	$75.11 - $113.76 $515,479 - $780,734	6,863 New	6,863 $243,000

Others Institutions Holding NBIX

# of Institutions

626

Shares Held

94M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.1B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Neurocrine Biosciences Inc Transaction History